1. Introduction {#sec1}
===============

Mycobacterium avium complex (MAC) lung disease is often observed in slim middle-aged and older women \[[@B1]--[@B4]\], and slenderness has been reported to serve as a prognostic factor \[[@B4], [@B5]\]. Although it is unclear how weight loss is involved with the etiology and pathology of MAC lung disease, the abnormal production of inflammatory cytokines due to fluctuations in adipocyte-derived adipokines, which is caused by a decrease in fat cells (particularly visceral fat cells) due to weight loss, has been suggested as one of the contributory factors \[[@B6]\]. In this context, it will be meaningful to investigate the association between weight loss and visceral fat area in patients with MAC lung disease, but no report exists with regard to weight loss and visceral fat area in patients with MAC lung disease. Moreover, while it is predicted that weight loss in patients with MAC lung disease is attributable to emaciation from the illness itself as well as low nutrient intake, no published reports pertaining to nutrient intake exist. Accordingly, this study aimed to examine the nutritional status and nutrient intake of patients with MAC lung disease with a focus on visceral fat area.

2. Patients and Methods {#sec2}
=======================

At our hospital, 116 outpatients and inpatients with NTM disease were registered between May 2010 and September 2013. Among these, 103 patients with MAC lung disease were included in this study. All patients met the diagnostic criteria of "An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases" \[[@B7]\] based on imaging and bacteriological examination findings, agreed with the study content, and provided written consent to participate in this study. We first compared nutritional status and nutritional intake between FC and NB dis. and found no differences between them. Accordingly, these two groups were combined.

Patients currently under treatment were defined as those undergoing a combination therapy that included clarithromycin or new quinolone antibacterial agents. Assessment of nutritional status included body mass index (BMI), lymphocyte count, serum albumin, serum prealbumin, serum cholinesterase, serum transferrin, total cholesterol, visceral fat area assessed by abdominal CT, and waist circumference. Measurements of visceral fat area and waist circumference were obtained from abdominal CT scans taken at the level of umbilicus using image analysis software (Fat Pointer; version 1.10, Hitachi Medical Corporation, Tokyo, Japan). Furthermore, BMI, waist circumference, and visceral fat area were compared with data of general adult participants of health checkups in 2008 FY (649 patients; 418 men, 231 women) from the Japanese Red Cross Kumamoto Hospital.

Information regarding dietary content and intake was obtained through interviews by nutritionists. Preliminarily, dietary and intake survey by nutritionists was done twice during a month period in ten patients with MAC lung disease, respectively, and we confirmed the reproducibility of results of the survey. Calorie intake, protein, lipid, and carbohydrate adequacy ratios (actual intake amount of each nutrient/average intake among Japanese people determined based on the 2010 National Nutrition Survey × 100) were determined.

Data were expressed as mean ± standard deviation (SD), since a test of normality showed that all data were normally distributed. *t*-tests were used for comparisons with data of general adults regarding visceral fat area. *p* \< 0.05 was considered statistically significant.

This study was conducted with the approval from the Ethics Board of the National Hospital Organization Omuta National Hospital.

3. Results {#sec3}
==========

3.1. Patient Characteristics {#sec3.1}
----------------------------

Our patients were predominantly female (24 men and 79 women), with an age range of 46--91 years and mean age of 71.3 ± 10.9 years at the time of registration. Disease duration (from the date of confirmed diagnosis to the point of registration) ranged from 0.93 to 311.8 months, with a mean duration of 78.5 ± 65.0 months. Detected bacterial strains were*M. intracellulare* in 59 patients,*M. avium* in 35, and*M. intracellulare* +*M. avium* in 9. Twenty-six patients had fibrocavitary (FC) disease, and 77 patients had nodular bronchiectatic (NB) disease ([Table 1](#tab1){ref-type="table"}).

3.2. Nutritional Status of Patients with MAC Lung Disease {#sec3.2}
---------------------------------------------------------

In both men and women, BMI, waist circumference, and visceral fat area at registration were significantly lower compared to data of health checkup participants according to age. In particular, visceral fat area was markedly lower than that of health checkup participants ([Table 2](#tab2){ref-type="table"}).

There was no significant difference in BMI between men and women, but women had a significantly lower visceral fat area. With respect to disease type, significantly more men had FC disease. In blood examination, serum prealbumin levels were low in both men (18.4 ± 4.8 mg/dL) and women (16.4 ± 4.4 mg/dL) compared to normal value of Japanese. However serum albumin, cholinesterase, transferrin, and total cholesterol levels were all within the normal ranges ([Table 1](#tab1){ref-type="table"}).

As for associations between visceral fat area and patient characteristics and laboratory findings, BMI, waist circumference, white blood cell count, and lymphocyte count were significantly correlated in men, but only BMI and waist circumference were significantly correlated in women ([Table 3](#tab3){ref-type="table"}).

3.3. Nutrient Intake of Patients with MAC Lung Disease {#sec3.3}
------------------------------------------------------

With respect to nutrient intake, energy adequacy (86.1 ± 15.7%), protein adequacy (82.4 ± 18.2%), lipid adequacy (78.1 ± 21.8%), and carbohydrate adequacy (89.6 ± 19.2%) ratios were low at the time of registration ([Table 4](#tab4){ref-type="table"}). BMI was significantly correlated with protein adequacy (*p* = 0.0397) and lipid adequacy (*p* = 0.0214) ratios ([Table 5](#tab5){ref-type="table"}). However visceral fat area was not significantly correlated with intake of each nutrient ([Table 6](#tab6){ref-type="table"}).

4. Discussion {#sec4}
=============

One of the clinical characteristics of MAC lung disease is its high prevalence among slim women. Kim et al. performed a prospective examination of 63 patients with NTM lung disease and reported that, compared with the background-matched control group, BMI was significantly lower \[[@B1]\]. Kartalija et al. also reported similar results in a prospective examination of 103 patients with NTM lung disease \[[@B2]\]. Moreover, in Japan, Okumura et al. reported that, in 273 patients with MAC lung disease, two-thirds were female and had a BMI lower than the standard BMI, irrespective of disease type (i.e., FC or NB) \[[@B3]\]. In the present study, most of our patients were women and had a BMI lower than that of general healthy controls. Although it is unclear how weight loss is involved with the etiology and pathology of MAC lung disease, the abnormal production of inflammatory cytokines due to fluctuations in adipocyte-derived adipokines, which is caused by a decrease in fat cells (particularly visceral fat cells) due to weight loss, has been suggested as one of the contributory factors \[[@B6]\]. Moreover, while it is predicted that weight loss in patients with MAC lung disease is attributable to emaciation from the illness itself as well as low nutrient intake, no published reports pertaining to nutrient intake exist. To our knowledge, this study is the first to examine visceral fat area and nutrient intake in patients with MAC lung disease.

In the present study, BMI, waist circumference, and particularly visceral fat area were significantly lower in both men and women compared with general healthy adults. Moreover, in this study, visceral fat area was strongly correlated with BMI and waist circumference, but not with patient characteristics or disease duration. Tasaka et al. showed a negative correlation between adiponectin and BMI and reported that, compared to healthy individuals, MAC patients had significantly higher levels of adiponectin according to weight \[[@B8]\]. The anti-inflammatory activities of adiponectin extend to inhibition of IL-6 production accompanied by induction of the anti-inflammatory cytokines IL-10 and IL-1 receptor antagonist and increased adiponectin leads to increased susceptibility to infections \[[@B9]\]. A decrease in visceral fat is possibly associated with the development of MAC lung disease, because Staiger et al. reported that a strong association exists between adiponectin and visceral fat \[[@B10]\].

That many patients with MAC lung disease are slim has been consistently shown as well as our patients; however, it is unclear why patients with NTM disease tend to be slim. The present study provides some insight in this regard, as it clearly showed that patients with MAC lung disease have low energy, protein, fat, and carbohydrate intake, which could partially explain why these patients are slim. BMI was significantly correlated with intake of protein and lipid intake. However, no significant correlation was found between visceral fat area and intake of each nutrient. These results suggest that the presence of factors other than nutrient intake might be related to reduced visceral fat. Nutrient intake might be related to subcutaneous fat and muscle mass. Decreased subcutaneous fat is considered to result in decrease of leptin, which may enhance the susceptibility to MAC. Although the present study had a cross-sectional design and thus did not examine prognoses, a number of previous studies have shown that low BMI is a prognostic factor for MAC lung disease \[[@B4], [@B5]\]. Future tasks may include an investigation of possible effects of nutritional guidance on the prognosis and course of disease in patients with MAC lung disease.

Other characteristics from the nutritional aspect included a decreased serum prealbumin level, but albumin levels were within the normal range. No study has examined serum prealbumin level in patients with MAC lung disease. Decreased serum prealbumin level might be associated with the pathological conditions of patients with MAC lung disease; however, the underlying mechanisms are unclear.

There are several limitations to this study. First, this was a single-facility study with a small number of male patients. Moreover, patient data were not from their first visit (i.e., varying duration of time had elapsed after diagnosis in each case). Furthermore, the control data used for comparison were data of those who had participated in health checkups and thus may not necessarily be considered data of the general healthy population. Though we have compared visceral fat and nutritional status between patients with MAC lung disease and healthy controls, comparison between MAC lung and nonpathogen related inflammatory lung diseases would make the argument more compelling. In addition, a thin population would be a better control group rather than general population as we used in the study. Previous studies used general population as control \[[@B1], [@B2]\]. Though we have compared nutritional intake of patients with MAC lung disease with average intake among Japanese people determined based on the 2010 National Nutrition Survey, comparison with healthy controls might be more appropriate. A multicenter study is warranted, and it will be necessary to perform an investigation regarding visceral fat area and patient prognosis, as well as a prospective study in which dietary intervention is performed with a focus on lipid and protein intake.

In conclusion, this study revealed that patients with MAC lung disease have a low visceral fat area and low nutrient intake, although no significant correlation was found between them. This suggests that factors other than nutrient intake may underlie the reduced visceral fat area.
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###### 

Baseline characteristics of patients with MAC lung disease (*n* = 103).

                               Normal ranges         Total (mean ± SD)              Female (mean ± SD)             Male (mean ± SD)               *p*
  ---------------------------- --------------------- ------------------------------ ------------------------------ ------------------------------ ----------
  Patient number                                     103                            79                             24                              
  Age (years)                                        72.3 ± 10.9                    72.7 ± 11.1                    71.2 ± 10.4                    0.5628
  Disease duration (months)                          78.5 ± 65.0                    78.7 ± 62.7                    77.9 ± 73.6 months             0.9562
  Smoking history                                    0/5^*∗*^/98                    0/0/79                         0/5^*∗*^/19                    0.0005
  Current/former/never                                                                                                                            
  Diabetes mellitus                                  9                              4                              5                              0.0301
  Emphysema                                          5^*∗∗*^                        0                              5^*∗∗*^                        0.0005
  Type of bacteria                                   *M. intracellulare 59* (57%)   *M. intracellulare 44* (56%)   *M. intracellulare 15* (63%)    
  *M. avium 35* (34%)          *M. avium 28* (35%)   *M. avium 7* (29%)                                                                           
  Both 9 (9%)                  Both 7 (9%)           Both 2 (8%)                                                                                  
  Radiographic features                                                                                                                            
   FC dis.                                           26                             14                             12                             0.0023
   NB dis.                                           77                             65                             12                             
  Number of patients treated                         71                             53                             18                             0.4649
  Height (cm)                                        154.0 ± 8.9                    150.9 ± 7.1                    164.2 ± 6.3                    \<0.0001
  Weight (kg)                                        46.3 ± 9.3                     43.8 ± 8.1                     54.8 ± 7.8                     \<0.0001
  BMI (kg/m^2^)                                      19.4 ± 2.9                     19.2 ± 2.9                     20.4 ± 2.7                     0.0780
  Visceral fat (cm^2^)                               41.0 ± 33.9                    35.7 ± 26.6                    57.5 ± 47.4                    0.0111
  Waist (cm)                                         73.3 ± 8.4                     72.5 ± 8.3                     75.9 ± 8.5                     0.0939
  WBC (/*μ*L)                  3100--8800            4968.6 ± 1559.1                4751.3 ± 1431.8                5675.0 ± 1769.1                0.0143
  Lymphocytes (/*μ*L)          837--4136             1404.9 ± 526.2                 1352.8 ± 456.8                 1574.4 ± 691.6                 0.0807
  Alb (g/dL)                   4.0--5.0              4.1 ± 0.3                      4.1 ± 0.3                      4.1 ± 0.3                      0.3883
  Ch-E (IU/L)                  214--466              309.8 ± 74.0                   309.5 ± 72.4                   310.9 ± 80.6                   0.9363
  T-chol (mg/dL)               128--219              186.6 ± 28.0                   190.9 ± 27.6                   173.0 ± 25.1                   0.0080
  Transferrin (mg/dL)          190--320              212.0 ± 49.6                   211.7 ± 43.1                   213.1 ± 67.7                   0.9013
  Prealbumin (mg/dL)           22.0--40.0            16.9 ± 4.5                     16.4 ± 4.4                     18.4 ± 4.8                     0.0662

Each parameter is displayed as mean ± standard deviation, except for patient number, comorbidity, type of bacteria, radiographic features, and number of patients treated.

FC dis.: fibrocavitary disease, NB dis.: nodular bronchiectatic disease, BMI: body mass index, WBC: white blood cell, Alb: albumin, Ch-E: cholinesterase, and T-chol: total cholesterol.

^*∗*^Three with FC dis. and two with NB dis.

^*∗∗*^Three with FC dis. and two with NB dis.

###### 

Visceral fat, body mass index, and waist circumference of patients with MAC lung disease according to age (*n* = 103).

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------
           Age (years)    Visceral fat (cm^2^)   *p* value       BMI (kg/m^2^)   *p* value     Waist (cm)    *p* value                                   
  -------- -------------- ---------------------- --------------- --------------- ------------- ------------- -------------- -------------- ------------- --------
  F        40\~59         33.7 ± 28.0\           69.5 ± 35.4\    0.0007          20.4 ± 1.8\   23.4 ± 3.8\   0.0050         73.9 ± 7.7\    83.5 ± 8.8\   0.0003
                          (*n* = 13)             (*n* = 99)                      (*n* = 13)    (*n* = 99)                   (*n* = 13)     (*n* = 99)    

  60\~69   33.1 ± 18.7\   88.4 ± 46.6\           \<0.0001        19.2 ± 2.9\     23.0 ± 3.2\   \<0.0001      75.1 ± 6.3\    84.5 ± 8.9\    0.0006        
           (*n* = 14)     (*n* = 43)                             (*n* = 17)      (*n* = 43)                  (*n* = 14)     (*n* = 43)                   

  70\~79   34.5 ± 30.5\   108.8 ± 44.1\          \<0.0001        18.4 ± 2.6\     23.2 ± 2.7\   \<0.0001      70.6 ± 8.2\    86.5 ± 7.3\    \<0.0001      
           (*n* = 20)     (*n* = 32)                             (*n* = 22)      (*n* = 32)                  (*n* = 20)     (*n* = 32)                   

  80\~     39.1 ± 27.4\   130.3 ± 51.8\          \<0.0001        19.2 ± 3.5\     24.1 ± 2.7\   0.0009        71.8 ± 9.6\    89.6 ± 8.6\    \<0.0001      
           (*n* = 25)     (*n* = 8)                              (*n* = 27)      (*n* = 8)                   (*n* = 25)     (*n* = 8)                    

                                                                                                                                                         

  M        50\~59         57.5 ± 42.8\           114.6 ± 43.3\   0.0258          21.7 ± 2.5\   24.5 ± 2.6\   0.0435         77.8 ± 14.0\   87.7 ± 7.1\   0.0217
                          (*n* = 3)              (*n* = 119)                     (*n* = 4)     (*n* = 119)                  (*n* = 3)      (*n* = 119)   

  60\~69   75.8 ± 58.2\   126.8 ± 56.1\          0.0346          19.7 ± 3.6\     24.4 ± 2.7\   0.0001        76.4 ± 11.0\   88.4 ± 8.4\    0.0014        
           (*n* = 6)      (*n* = 82)                             (*n* = 6)       (*n* = 82)                  (*n* = 6)      (*n* = 82)                   

  70\~79   39.7 ± 40.0\   126.8 ± 45.2\          \<0.0001        20.4 ± 2.8\     24.1 ± 2.1\   0.0002        75.0 ± 6.6\    86.9 ± 5.8\    \<0.0001      
           (*n* = 8)      (*n* = 32)                             (*n* = 8)       (*n* = 32)                  (*n* = 8)      (*n* = 32)                   

  80\~     63.1 ± 50.5\   123.4 ± 50.5\          0.0368          20.1 ± 1.9\     23.8 ± 3.0\   0.0185        75.8 ± 7.1\    87.9 ± 9.0\    0.0141        
           (*n* = 6)      (*n* = 10)                             (*n* = 6)       (*n* = 10)                  (*n* = 6)      (*n* = 10)                   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are presented as mean ± standard deviation.

F: female, M: male, and BMI: body mass index.

###### 

Correlation analyses between visceral fat area and each parameter in patients with MAC lung disease.

  Parameter          Female    Male                 
  ------------------ --------- ---------- --------- ----------
  Age                0.0325    0.7864     −0.0290   0.8955
  Disease duration   0.0010    0.9935     0.3908    0.0652
  BMI                0.5996    \<0.0001   0.7534    \<0.0001
  Waist              0.7120    \<0.0001   0.8425    \<0.0001
  WBC                0.0571    0.6364     0.5196    0.0110
  Lymphocyte         0.0654    0.5882     0.6337    0.0012
  Albumin            0.1447    0.2287     0.3879    0.0674
  Ch-E               −0.0545   0.6519     0.2396    0.2709
  T-chol             −0.1602   0.1819     0.1181    0.5916
  Transferrin        0.0115    0.9241     −0.0547   0.8041
  Prealbumin         0.1019    0.3977     0.5789    0.0038
  CRP                −0.1876   0.1145     0.0905    0.6813

BMI: body mass index, WBC: white blood cell, Ch-E: cholinesterase, T-chol: total cholesterol, and CRP: C-reactive protein.

###### 

Intake (%) of energy and each nutrient in patients with MAC lung disease.

  --------------------------------
                     Total\
                     Mean ± SD
  ------------------ -------------
  Energy (%)         86.1 ± 15.7

  Protein (%)        82.4 ± 18.2

  Lipid (%)          78.1 ± 21.8

  Carbohydrate (%)   89.6 ± 19.2
  --------------------------------

Data are presented as mean ± standard deviation.

Intake (%) of energy and each nutrient was calculated by dividing the actual intake by the average intake among Japanese people determined based on the 2010 National Nutrition Survey × 100.

###### 

Correlation analyses between body mass index and intake (%) of energy and each nutrient in patients with MAC lung disease.

  Parameter          *r*      *p* value
  ------------------ -------- -----------
  Energy (%)         0.1961   0.0568
  Protein (%)        0.2114   0.0397
  Lipid (%)          0.2359   0.0214
  Carbohydrate (%)   0.1092   0.2920

Intake (%) of energy and each nutrient was calculated by dividing the actual intake by the average intake among Japanese people determined based on the 2010 National Nutrition Survey × 100.

###### 

Correlation analyses between visceral fat area and intake (%) of energy and each nutrient in patients with MAC lung disease.

  Parameter          *r*       *p*-value
  ------------------ --------- -----------
  Energy (%)         −0.0242   0.8243
  Protein (%)        0.0401    0.7123
  Lipid (%)          −0.0103   0.9248
  Carbohydrate (%)   −0.0025   0.9818

Intake (%) of energy and each nutrient was calculated by dividing the actual intake by the average intake among Japanese people determined based on the 2010 National Nutrition Survey × 100.
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